LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein
Kailin Chen, Sai-Wei Huang, Ji‐Jin Yao, Shiwei He, Sha Gong, Xi-Rong Tan, Ye‐Lin Liang, Junyan Li, Sheng‐Yan Huang, Ying‐Qin Li, Yin Zhao, Han Qiao, Sha Xu, Shengbing Zang, Jun Ma, Na Liu
Topics & Concepts
Nasopharyngeal carcinomaCancer researchGemcitabineUbiquitin ligaseDownregulation and upregulationBiomarkerBiologyDNA repairChemotherapyUbiquitinRadiation therapyMedicineDNAInternal medicineGeneGeneticsCancer-related molecular mechanisms researchRNA modifications and cancerViral-associated cancers and disorders